Details for New Drug Application (NDA): 201676
✉ Email this page to a colleague
The generic ingredient in SIROLIMUS is sirolimus. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sirolimus profile page.
Summary for 201676
| Tradename: | SIROLIMUS |
| Applicant: | Zydus Pharms |
| Ingredient: | sirolimus |
| Patents: | 0 |
Pharmacology for NDA: 201676
| Mechanism of Action | Protein Kinase Inhibitors mTOR Inhibitors |
| Physiological Effect | Decreased Immunologic Activity |
Medical Subject Heading (MeSH) Categories for 201676
Suppliers and Packaging for NDA: 201676
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SIROLIMUS | sirolimus | TABLET;ORAL | 201676 | ANDA | American Health Packaging | 60687-902 | 60687-902-21 | 30 BLISTER PACK in 1 CARTON (60687-902-21) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-902-11) |
| SIROLIMUS | sirolimus | TABLET;ORAL | 201676 | ANDA | Zydus Lifesciences Limited | 65841-771 | 65841-771-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65841-771-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Feb 15, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Feb 15, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Jan 8, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
